Negative Regulation of Myeloid-derived Suppressor Cells in Cancer

REFERENCES

• Adeegbe, D., Serafini, P., Bronte, V., Zoso, A., Ricordi, C., Inverardi, L. (2011). In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice. Cell Transplant. 20:941–954.
   PubMed Web of Science ®Google Scholar
• Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001). Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166:678–689.
   PubMed Web of Science ®Google Scholar
• Boelte, K. C., Gordy, L. E., Joyce, S., Thompson, M. A., Yang, L., Lin, P. C. (2011). Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PloS One 6:e18534.
   Web of Science ®Google Scholar
• Bogdan, C. (2011). Regulation of lymphocytes by nitric oxide. Meth. Mol. Biol. 677:375–393.
   PubMedGoogle Scholar
• Boutte, A. M., McDonald, W. H., Shyr, Y., Yang, L., Lin, P. C. (2011). Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomics. PloS One 6: e22446.
   Web of Science ®Google Scholar
• Bronstein-Sitton, N., Cohen-Daniel, L., Vaknin, I., Ezernitchi, A. V., Leshem, B., Halabi, A., Houri-Hadad, Y., Greenbaum, E., Zakay-Rones, Z., Shapira, L., Baniyash, M. (2003). Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. Nat. Immunol. 4:957–964.
   PubMed Web of Science ®Google Scholar
• Bronte, V. (2009). Myeloid-derived suppressor cells in inflammation: Uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39:2670–2672.
   PubMed Web of Science ®Google Scholar
• Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., Zanovello, P. (2000). Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96:3838–3846.
   PubMed Web of Science ®Google Scholar
• Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., Restifo, N. P. (1999). Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162:5728–5737.
   PubMed Web of Science ®Google Scholar
• Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., (2003a). IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170:270–278.
   PubMed Web of Science ®Google Scholar
• Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., Zanovello, P. (2003b). L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24:302–306.
   PubMed Web of Science ®Google Scholar
• Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., Restifo, N. P. (1998). Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J. Immunol. 161:5313–5320.
   PubMed Web of Science ®Google Scholar
• Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., and Ostrand-Rosenberg, S. (2009). Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J. Leukocyte Biol. 85:996–1004.
   PubMed Web of Science ®Google Scholar
• Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2006). Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176:284–290.
   PubMed Web of Science ®Google Scholar
• Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2007). Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67: 10019–10026.
   PubMed Web of Science ®Google Scholar
• Chaudhuri, A. A., So, A. Y., Sinha, N., Gibson, W. S., Taganov, K. D., O’Connell, R. M., Baltimore, D. (2011). MicroRNA-125b potentiates macrophage activation. J. Immunol. 187:5062–5068.
   PubMed Web of Science ®Google Scholar
• Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis, E., Quiceno, D. G., Padhya, T., (2010). HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exper. Med. 207:2439–2453.
   PubMed Web of Science ®Google Scholar
• Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2009). Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol.182, 5693–5701.
   PubMed Web of Science ®Google Scholar
• De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., (2005). Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Nat’l. Acad. Sci. USA 104:4185–4190.
   Google Scholar
• De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J. F., Lemaitre, P., Lhomme, F., Kubjak, C., Vokaer, B., Oldenhove, G., Charbonnier, L. M., (2009). Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9:2034–2047.
   PubMed Web of Science ®Google Scholar
• Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O’Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., (2007). MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exper. Med. 204:1463–1474.
   PubMed Web of Science ®Google Scholar
• Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., Pikarsky, E., Shapira, L., Baniyash, M. (2006). TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. J. Immunol. 177:4763–4772.
   PubMed Web of Science ®Google Scholar
• Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., Albelda, S. M. (2012). Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PloS One 7: e31524.
   PubMed Web of Science ®Google Scholar
• Fu, H., Hu, Z., Wen, J., Wang, K., Liu, Y. (2009). TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim. Biophys. Sinica 41:648–656.
   PubMed Web of Science ®Google Scholar
• Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R. L., Komohara, Y., Decker, S. A., Ohlfest, J. R., Okada, H. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res. 71:2664–2674.
   PubMed Web of Science ®Google Scholar
• Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D. P. (1998). Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92:4150–4166.
   PubMed Web of Science ®Google Scholar
• Gabrilovich, D. I., Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nature Rev. Immunol. 9:162–174.
   PubMed Web of Science ®Google Scholar
• Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., Kast, W. M. (2001). Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166:5398–5406.
   PubMed Web of Science ®Google Scholar
• Garcia, M. R., Ledgerwood, L., Yang, Y., Xu, J., Lal, G., Burrell, B., Ma, G., Hashimoto, D., Li, Y., Boros, P., (2010). Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Investig. 120:2486–2496.
   PubMed Web of Science ®Google Scholar
• Greten, T. F., Manns, M. P., Korangy, F. (2011). Myeloid derived suppressor cells in human diseases. Inter. Immunopharmacol. 11:802–807.
   PubMed Web of Science ®Google Scholar
• Haile, L. A., Gamrekelashvili, J., Manns, M. P., Korangy, F., Greten, T. F. (2010). CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J. Immunol. 185:203–210.
   PubMed Web of Science ®Google Scholar
• Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., Ostrand-Rosenberg, S. (2009). Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J. Immunol. 183:937–944.
   PubMed Web of Science ®Google Scholar
• Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten, T. F., Korangy, F. (2008). A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135:234–243.
   PubMed Web of Science ®Google Scholar
• Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., Chen, S. H. (2006). Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66:1123–1131.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Chen, X., Dikov, M. M., Novitskiy, S. V., Mosse, C. A., Yang, L., Carbone, D. P. (2007). Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood 110:624–631.
   PubMed Web of Science ®Google Scholar
• Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., Camargo, F. D. (2008). Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125–1129.
   PubMed Web of Science ®Google Scholar
• Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., Breyer, R. M., and Lin, P. C. (2006). EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 25:7019–7028.
   PubMed Web of Science ®Google Scholar
• Kerr, E. C., Raveney, B. J., Copland, D. A., Dick, A. D., Nicholson, L. B. (2008). Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun. 31:354–361.
   PubMed Web of Science ®Google Scholar
• Ko, H. J., Kim, Y. J., Kim, Y. S., Chang, W. S., Ko, S. Y., Chang, S. Y., Sakaguchi, S., Kang, C. Y. (2007). A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. Cancer Res. 67:7477–7486.
   PubMed Web of Science ®Google Scholar
• Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., and Yu, H. (2008). Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Investig. 118:3367–3377.
   PubMed Web of Science ®Google Scholar
• Kujawski, M., Zhang, C., Herrmann, A., Reckamp, K., Scuto, A., Jensen, M., Deng, J., Forman, S., Figlin, R., Yu, H. (2010). Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects. Cancer Res. 70:9599–9610.
   PubMed Web of Science ®Google Scholar
• Kusmartsev, S., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E., Lush, R., Gabrilovich, D. (2003). All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63:4441–4449.
   PubMed Web of Science ®Google Scholar
• Kusmartsev, S., Gabrilovich, D. I. (2005). STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174:4880–4891.
   PubMed Web of Science ®Google Scholar
• Kusmartsev, S., Nagaraj, S., Gabrilovich, D. I. (2005). Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175:4583–4592.
   PubMed Web of Science ®Google Scholar
• Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D. I. (2004). Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172:989–999.
   PubMed Web of Science ®Google Scholar
• Lechner, M. G., Megiel, C., Russell, S. M., Bingham, B., Arger, N., Woo, T., Epstein, A. L. (2011). Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J. Trans. Med. 9:90.
   PubMed Web of Science ®Google Scholar
• Lees, J. R., Azimzadeh, A. M., Bromberg, J. S. (2011). Myeloid derived suppressor cells in transplantation. Curr. Opin. Immunol. 23:692–697.
   PubMed Web of Science ®Google Scholar
• Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C., Hirschhorn-Cymerman, D., Avogadri, F., Rizzuto, G. A., Lazarus, J. J., Pamer, E. G., Houghton, A. N., (2012). Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 72:876–886.
   PubMed Web of Science ®Google Scholar
• Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X. (2009). Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J. Immunol. 182:240–249.
   PubMed Web of Science ®Google Scholar
• Li, Q., Pan, P. Y., Gu, P., Xu, D., Chen, S. H. (2004). Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Cancer Res. 64:1130–1139.
   PubMed Web of Science ®Google Scholar
• Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., Zhang, H. G. (2007). Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 109:4336–4342.
   PubMed Web of Science ®Google Scholar
• Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Pisarev, V., Sherman, S., Sporn, M. B., Gabrilovich, D. (2011a). Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Investig. 121:4015–4029.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Jiang, F., Zheng, X., Katakowski, M., Buller, B., To, S. S., Chopp, M. (2011b). TGF-beta1 promotes motility and invasiveness of glioma cells through activation of ADAM17. Oncol. Repts. 25:1329–1335.
   PubMed Web of Science ®Google Scholar
• Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549–555.
   PubMed Web of Science ®Google Scholar
• Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., and Segal, D. M. (2002). Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168:689–695.
   PubMed Web of Science ®Google Scholar
• Melani, C., Chiodoni, C., Forni, G., Colombo, M. P. (2003). Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102:2138–2145.
   PubMed Web of Science ®Google Scholar
• Min, Y., Ghose, S., Boelte, K., Li, J., Yang, L., Lin, P. C. (2011). C/EBP-delta regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1alpha. Oncogene 30:4901–4909.
   PubMed Web of Science ®Google Scholar
• Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., Lush, R. M., Antonia, S., Gabrilovich, D. I. (2006). All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 66:9299–9307.
   PubMed Web of Science ®Google Scholar
• Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008). Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111:4233–4244.
   PubMed Web of Science ®Google Scholar
• Nagaraj, S., Gabrilovich, D. I. (2010). Myeloid-derived suppressor cells in human cancer. Cancer J. 16:348–353.
   PubMed Web of Science ®Google Scholar
• Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., Gabrilovich, D. I. (2007). Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nature Med. 13:828–835.
   PubMed Web of Science ®Google Scholar
• Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E., Gabrilovich, D. I. (2010). Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184:3106–3116.
   PubMed Web of Science ®Google Scholar
• Nefedova, Y., Gabrilovich, D. I. (2007). Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Curr. Cancer Drug Targets 7:71–77.
   PubMed Web of Science ®Google Scholar
• O’Connell, R. M., Rao, D. S., Baltimore, D. (2012). MicroRNA regulation of inflammatory responses. Ann. Rev. Immunol.30:295–312.
   Google Scholar
• O’Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J., Paquette, R. L., Baltimore, D. (2008). Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exper. Med. 205, 585–594.
   PubMed Web of Science ®Google Scholar
• O’Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104:1604–1609.
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg, S., Sinha, P. (2009). Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499–4506.
   PubMed Web of Science ®Google Scholar
• Pan, P. Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M., Chen, S. H. (2010). Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70:99–108.
   PubMed Web of Science ®Google Scholar
• Park, Y. S., Bae, J. H., Son, C. H., Lee, K. S., Kim, W., Jung, M. H., Yang, K., Kim, S. H., Kang, C. D. (2011). Cyclophosphamide potentiates the antitumor effect of immunization with injection of immature dendritic cells into irradiated tumor. Immunol. Invest. 40:383–399.
   PubMed Web of Science ®Google Scholar
• Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V. (2010). Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22:238–244.
   PubMed Web of Science ®Google Scholar
• Prins, R. M., Scott, G. P., Merchant, R. E., Graf, M. R. (2002). Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression. Cancer Immunol. Immunother. 51:190–199.
   PubMed Web of Science ®Google Scholar
• Qu, P., Du, H., Li, Y., Yan, C. (2009a). Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung. J. Immunol. 182:1648–1659.
   PubMed Web of Science ®Google Scholar
• Qu, P., Du, H., Wang, X., Yan, C. (2009b). Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition. Cancer Res. 69:7252–7261.
   PubMed Web of Science ®Google Scholar
• Qu, P., Yan, C., Blum, J. S., Kapur, R., and Du, H. (2011a). Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice. J. Immunol. 187:3854–3866.
   PubMed Web of Science ®Google Scholar
• Qu, P., Yan, C., Du, H. (2011b). Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis. Blood 117:4476–4489.
   PubMed Web of Science ®Google Scholar
• Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., Ochoa, A. C. (2009). Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69:1553–1560.
   PubMed Web of Science ®Google Scholar
• Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., Ochoa, A. C. (2005). Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exper. Med. 202:931–939.
   PubMed Web of Science ®Google Scholar
• Rodriguez, P. C., Zea, A. H., Ochoa, A. C. (2003). Mechanisms of tumor evasion from the immune response. Cancer Chemother. Biolog. Respon. Modif. 21:351–364.
   PubMedGoogle Scholar
• Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., Murphy, W. J. (2000). Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 96:34–40.
   PubMed Web of Science ®Google Scholar
• Serafini, P., Borrello, I., Bronte, V. (2006a). Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16:53–65.
   PubMed Web of Science ®Google Scholar
• Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., Borrello, I. (2004a). High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64:6337–6343.
   PubMed Web of Science ®Google Scholar
• Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., Bronte, V. (2004b). Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. CII 53:64–72.
   PubMed Web of Science ®Google Scholar
• Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., Borrello, I. (2006b). Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J. Exp. Med. 203:2691–2702.
   PubMed Web of Science ®Google Scholar
• Serafini, P., Mgebroff, S., Noonan, K., and Borrello, I. (2008). Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68:5439–5449.
   PubMed Web of Science ®Google Scholar
• Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H. P., and Ferrara, N. (2007). Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat. Biotechnol. 25:911–920.
   PubMed Web of Science ®Google Scholar
• Sica, A., and Bronte, V. (2007). Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Investig. 117:1155–1166.
   PubMed Web of Science ®Google Scholar
• Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007a). Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179:977–983.
   PubMed Web of Science ®Google Scholar
• Sinha, P., Clements, V. K., Fulton, A. M., Ostrand-Rosenberg, S. (2007b). Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67:4507–4513.
   PubMed Web of Science ®Google Scholar
• Sinha, P., Clements, V. K., Ostrand-Rosenberg, S. (2005). Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174:636–645.
   PubMed Web of Science ®Google Scholar
• Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., and Srikrishna, G. (2008). Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181:4666–4675.
   PubMed Web of Science ®Google Scholar
• Solheim, J. C., Reber, A. J., Ashour, A. E., Robinson, S., Futakuchi, M., Kurz, S. G., Hood, K., Fields, R. R., Shafer, L. R., Cornell, D., (2007). Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Ther. 14:364–371.
   PubMed Web of Science ®Google Scholar
• Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., Ostrand-Rosenberg, S. (2010). Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70:68–77.
   PubMed Web of Science ®Google Scholar
• Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., Albelda, S. M. (2005). Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin. Cancer Res. 11: 6713–6721.
   PubMed Web of Science ®Google Scholar
• Taganov, K. D., Boldin, M. P., Chang, K. J., Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103:12481–12486.
   PubMed Web of Science ®Google Scholar
• Talmadge, J. E., Hood, K. C., Zobel, L. C., Shafer, L. R., Coles, M., Toth, B. (2007). Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int. Immunopharmacol. 7:140–151.
   PubMed Web of Science ®Google Scholar
• Varga, G., Ehrchen, J., Tsianakas, A., Tenbrock, K., Rattenholl, A., Seeliger, S., Mack, M., Roth, J., Sunderkoetter, C. (2008). Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J. Leukoc. Biol. 84:644–650.
   PubMed Web of Science ®Google Scholar
• Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., Lin, P. C. (2004). Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409–421.
   PubMed Web of Science ®Google Scholar
• Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., Moses, H. L. (2008). Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:23–35.
   PubMed Web of Science ®Google Scholar
• Yang, R., Cai, Z., Zhang, Y., Yutzy, W. H. t., Roby, K. F., Roden, R. B. (2006). CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66:6807–6815.
   PubMed Web of Science ®Google Scholar
• Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K., Gabrilovich, D. I. (2012). Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukocyte Biol. 91:167–181.
   PubMed Web of Science ®Google Scholar
• Youn, J. I., Nagaraj, S., Collazo, M., and Gabrilovich, D. I. (2008). Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791–5802.
   PubMed Web of Science ®Google Scholar
• Younos, I., Donkor, M., Hoke, T., Dafferner, A., Samson, H., Westphal, S., Talmadge, J. (2011). Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Inter. Immunopharmacol. 11:816–826.
   PubMed Web of Science ®Google Scholar
• Yu, B., Kusmartsev, S., Cheng, F., Paolini, M., Nefedova, Y., Sotomayor, E., Gabrilovich, D. (2003). Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clin. Cancer Res. 9:285–294.
   PubMed Web of Science ®Google Scholar
• Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O’Neill, A., (2005). Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65:3044–3048.
   PubMed Web of Science ®Google Scholar
• Zhang, M., Liu, Q., Mi, S., Liang, X., Zhang, Z., Su, X., Liu, J., Chen, Y., Wang, M., Zhang, Y., (2011). Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J. Immunol. 186:4716–4724.
   PubMed Web of Science ®Google Scholar
• Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O’Connell, R. M., Baltimore, D. (2011). NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108:9184–9189.
   PubMed Web of Science ®Google Scholar
• Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., Khoury, S. J. (2007). CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179:5228–5237.
   PubMed Web of Science ®Google Scholar